CONTENTS:
- Of moral judgments and sexual addictions [Editorial]. Humphreys K., p. 387-388.
- Reflections on addiction research centres and the nurturing of creativity. O'Reilly J., West R., p. 389-390.
- How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor [Addiction debate]. Villanti A.C., Feirman S.P., Niaura R.S., Pearson J.L., Glasser A.M., Collins L.K., et al., p. 391-404.
- Applying recommended evidence standards to understand the impact of e-cigarettes on youth smoking and reporting of weak scientific evidence. Green M.J., Hilton S., p. 405-406.
- Moving beyond vaping as a cessation-only practice. Weier M., p. 406-407.
- Answering the question or questioning the answer? Robson D., McNeill A., p. 407-409.
- Fostering transparency in e-cigarette research synthesis: the utility and limitations of methodological hierarchies. Villanti A.C., Niaura R.S., Pearson J.L., Glasser A.M., Abrams D.B., p. 409-410.
- Measuring treatment outcomes in gambling disorders: a systematic review. Pickering D., Keen B., Entwistle G., Blaszczynski A., p. 411-426.
- Commentary on Pickering et al. (2018): Problems with measurement consistency - unique to gambling or widespread in addictions? Petry N.M., Hodgins D.C., p. 427-428.
- The short-term impact of the alcohol act on alcohol-related deaths and hospital admissions in Scotland: a natural experiment. Robinson M., Bouttell J., Lewsey J., Mackay D., McCartney G., Beeston C., p. 429-439.
- A developmental-based motivational intervention to reduce alcohol and marijuana use among non-treatment-seeking young adults: a randomized controlled trial. Stein M.D., Caviness C.M., Morse E.F., Grimone K.R., Audet D., Herman D.S., et al., p. 440-453.
- Socio-economic differentials in cannabis use trends in Australia. Chan G.C.K., Leung J., Quinn C., Weier M., Hall W., p. 454-461.
- Commentary on Chan et al. (2018): Cannabis use and educational level - which is the chicken and which is the egg? Melchior M., Azevedo da Silva M., p. 462-463.
- Non-medical use of psychoactive prescription drugs is associated with fatal poisoning. Haukka J., Kriikku P., Mariottini C., Partonen T., Ojanperä I., p. 464-472.
- Trends and age, period and cohort effects for marijuana use prevalence in the 1984-2015 US National Alcohol Surveys. Kerr W.C., Lui C., Ye Y., p. 473-481.
- Commentary on Kerr et al. (2018): Marijuana, drug use, and mental health in the United States - a tale of two generations. Keyes K.M., p. 482-483.
- Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study. McDonald R., Lorch U., Woodward J., Bosse B., Dooner H., Mundin G., et al., p. 484-493.
- Commentary on McDonald et al. (2018): Intranasal naloxone - from the laboratory to the real world. Nielsen S., Larney S., Farrell M., p. 494-495.
- Moral disapproval and perceived addiction to internet pornography: a longitudinal examination. Grubbs J.B., Wilt J.A., Exline J.J., Pargament K.I., Kraus S.W., p. 496-506.
- Commentary on Grubbs et al. (2018): Coming out as a pornography user - could societal acceptance decrease the prevalence of perceived addiction? Weingardt K.R., p. 507-508.
- Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Chenoweth M.J., Ware J.J., Zhu A.Z.X., Cole C.B., Cox L.S., Nollen N., et al., p. 509-523.
- Trends in age of smoking initiation in the Netherlands: a shift towards older ages? Nuyts P.A.W., Kuipers M.A.G., Willemsen M.C., Kunst A.E., p. 524-532.
- Commentary on Nuyts et al. (2018): Education is the key to preventing growing inequalities in smoking prevalence. Maynard O.M., Gage S.H., p. 533-534.
- The effect of a behavioral activation treatment for substance use on post-treatment abstinence: a randomized controlled trial. Daughters S.B., Magidson J.F., Anand D., Seitz-Brown C.J., Chen Y., Baker S., p. 535-544.
- Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Platt L., Minozzi S., Reed J., Vickerman P., Hagan H., French C., et al., p. 545-563.
- Addiction Lives: Wayne Hall. Berridge V., p. 564-567.
- Addiction research centres and the nurturing of creativity: The Centre for Alcohol Policy Research (CAPR), Melbourne: a decade on. Wilkinson C., Pennay A., MacLean S., Livingston M., Room R., Hamilton M., et al., p. 568-574.
- Consideration of use opportunities, novel products, and user modes in cannabis monitoring, research, and policy: a response to the commentary. Burdzovic Andreas J., Bretteville-Jensen A.L., p. 575-576.
- Response to Kypri's commentary on Moore: red tape, the limitations of policy and a science of prevention. Moore S.C., p. 576-577.
- Tuibur: tobacco in a bottle - commercial production of tobacco smoke-saturated aqueous concentrate. Madathil S., Senthil Kumar N., Zodinpuii D., Muthukumaran R.B., Lalmuanpuii R., Nicolau B., p. 577-580.